Philip A. Read

Targeted Left Ventricular Lead Placement to Guide Cardiac Resynchronization Therapy

Fakhar Z. Khan, Mumohan S. Virdee, Christopher R. Palmer et al. · Journal of the American College of Cardiology · 2012 · 648 citations

Heart Failure, Device Therapy, Cardiovascular Disease +5

DPP-4 Inhibition by Sitagliptin Improves the Myocardial Response to Dobutamine Stress and Mitigates Stunning in a Pilot Study of Patients With Coronary Artery Disease

Philip A. Read, Fakhar Z. Khan, Patrick M. Heck et al. · Circulation Cardiovascular Imaging · 2010 · 227 citations · Full text

A Pilot Study to Assess Whether Glucagon-Like Peptide-1 Protects the Heart From Ischemic Dysfunction and Attenuates Stunning After Coronary Balloon Occlusion in Humans

Philip A. Read, Stephen P. Hoole, Paul A. White et al. · Circulation Cardiovascular Interventions · 2011 · 119 citations · Full text

Cardioprotection against ischaemia induced by dobutamine stress using glucagon-like peptide-1 in patients with coronary artery disease

Philip A. Read, Fakhar Z. Khan, David P. Dutka · Heart · 2011 · 113 citations

Chronic Dipeptidyl Peptidase-4 Inhibition With Sitagliptin Is Associated With Sustained Protection Against Ischemic Left Ventricular Dysfunction in a Pilot Study of Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

Liam McCormick, A. Kydd, Philip A. Read et al. · Circulation Cardiovascular Imaging · 2014 · 59 citations · Full text